Sustained Release Agent

Incorporating poorly soluble drugs into polymeric nanoparticles is a widely investigated approach to improve their biopharmaceutical performance. Poly(DL-lactide-co-glycolide) (PLGA) nanoparticle...

Modified- or sustained-release matrices are designed to release a drug slowly over an extended period of time. Formulations must be...

Anti-HIV drug Lamivudine exhibit shorter half-life (2 h) and poor bioavailability (62% in paediatric patients), multiple dosing is required. To overcome...

We present the design of a novel pH-responsive drug release system that is achieved by solventless encapsulation of drugs within...

new family of cellulosic ether polymeric excipients has been recently engineered for fabrication of amorphous solid dispersions (ASDs) of active...

Dissolution of poorly water-soluble active pharmaceutical ingredients (APIs) in polymeric melts plays an important role in the manufacturing of solid...

Oral modied-release multiparticulate dosage forms, which are also referred to as oral multiple-unit particulate systems, are becoming increasingly popular for...

The principal method of drug delivery is by oral solid doses, the production of which often necessitates multiple post-crystallization unit...

  07. June 2018 3D printing evolved as a promising technique to improve individualization of drug therapy. In particular, when...